Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey.

Asangbeh-Kerman, Serra Lem; Davidović, Maša; Taghavi, Katayoun; Dhokotera, Tafadzwa; Manasyan, Albert; Sharma, Anjali; Jaquet, Antoine; Musick, Beverly; Twizere, Christella; Chimbetete, Cleophas; Murenzi, Gad; Tweya, Hannock; Muhairwe, Josephine; Wools-Kaloustian, Kara; Technau, Karl-Gunter; Anastos, Kathryn; Yotebieng, Marcel; Jousse, Marielle; Ezechi, Oliver; Orang'o, Omenge; ... (2024). Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey. Journal of the International AIDS Society, 27(7), e26303. BioMed Central 10.1002/jia2.26303

[img]
Preview
Text
Asangbeh-Kerman_JIntAIDSSoc_2024.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (1MB) | Preview

INTRODUCTION

To eliminate cervical cancer (CC), access to and quality of prevention and care services must be monitored, particularly for women living with HIV (WLHIV). We assessed implementation practices in HIV clinics across sub-Saharan Africa (SSA) to identify gaps in the care cascade and used aggregated patient data to populate cascades for WLHIV attending HIV clinics.

METHODS

Our facility-based survey was administered between November 2020 and July 2021 in 30 HIV clinics across SSA that participate in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. We performed a qualitative site-level assessment of CC prevention and care services and analysed data from routine care of WLHIV in SSA.

RESULTS

Human papillomavirus (HPV) vaccination was offered in 33% of sites. Referral for CC diagnosis (42%) and treatment (70%) was common, but not free at about 50% of sites. Most sites had electronic health information systems (90%), but data to inform indicators to monitor global targets for CC elimination in WLHIV were not routinely collected in these sites. Data were collected routinely in only 36% of sites that offered HPV vaccination, 33% of sites that offered cervical screening and 20% of sites that offered pre-cancer and CC treatment.

CONCLUSIONS

Though CC prevention and care services have long been available in some HIV clinics across SSA, patient and programme monitoring need to be improved. Countries should consider leveraging their existing health information systems and use monitoring tools provided by the World Health Organization to improve CC prevention programmes and access, and to track their progress towards the goal of eliminating CC.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

Graduate School:

Graduate School for Cellular and Biomedical Sciences (GCB)
Graduate School for Health Sciences (GHS)

UniBE Contributor:

Taghavi, Katayoun, Bohlius, Julia Friederike

Subjects:

600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

1758-2652

Publisher:

BioMed Central

Funders:

[4] Swiss National Science Foundation ; [211] NIH National Institute of Allergy and Infectious Diseases

Language:

English

Submitter:

Pubmed Import

Date Deposited:

10 Jul 2024 10:29

Last Modified:

19 Jul 2024 09:04

Publisher DOI:

10.1002/jia2.26303

PubMed ID:

38979918

Uncontrolled Keywords:

HIV cervical cancer prevention monitoring outcomes prevention and care cascades sub‐Saharan Africa

BORIS DOI:

10.48350/198832

URI:

https://boris.unibe.ch/id/eprint/198832

Actions (login required)

Edit item Edit item
Provide Feedback